155 related articles for article (PubMed ID: 12560513)
1. Design of artificial transcription factors to selectively regulate the pro-apoptotic bax gene.
Falke D; Fisher M; Ye D; Juliano RL
Nucleic Acids Res; 2003 Feb; 31(3):e10. PubMed ID: 12560513
[TBL] [Abstract][Full Text] [Related]
2. Selective transcription of p53 target genes by zinc finger-p53 DNA binding domain chimeras.
Falke D; Fisher MH; Juliano RL
Biochim Biophys Acta; 2004 Nov; 1681(1):15-27. PubMed ID: 15566940
[TBL] [Abstract][Full Text] [Related]
3. The activity of the murine Bax promoter is regulated by Sp1/3 and E-box binding proteins but not by p53.
Schmidt T; Körner K; Karsunky H; Korsmeyer S; Müller R; Möröy T
Cell Death Differ; 1999 Sep; 6(9):873-82. PubMed ID: 10510469
[TBL] [Abstract][Full Text] [Related]
4. Distinct promoter elements mediate the co-operative effect of Brn-3a and p53 on the p21 promoter and their antagonism on the Bax promoter.
Perez-Sanchez C; Budhram-Mahadeo VS; Latchman DS
Nucleic Acids Res; 2002 Nov; 30(22):4872-80. PubMed ID: 12433990
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.
Miyashita T; Reed JC
Cell; 1995 Jan; 80(2):293-9. PubMed ID: 7834749
[TBL] [Abstract][Full Text] [Related]
6. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes.
Thornborrow EC; Patel S; Mastropietro AE; Schwartzfarb EM; Manfredi JJ
Oncogene; 2002 Feb; 21(7):990-9. PubMed ID: 11850816
[TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor protein p53 requires a cofactor to activate transcriptionally the human BAX promoter.
Thornborrow EC; Manfredi JJ
J Biol Chem; 2001 May; 276(19):15598-608. PubMed ID: 11278953
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIF-1- and wild-type p53-stimulated transcription by codon Arg175 p53 mutants with selective loss of functions.
Blagosklonny MV; Giannakakou P; Romanova LY; Ryan KM; Vousden KH; Fojo T
Carcinogenesis; 2001 Jun; 22(6):861-7. PubMed ID: 11375890
[TBL] [Abstract][Full Text] [Related]
9. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
Hemmati PG; Gillissen B; von Haefen C; Wendt J; Stärck L; Güner D; Dörken B; Daniel PT
Oncogene; 2002 May; 21(20):3149-61. PubMed ID: 12082630
[TBL] [Abstract][Full Text] [Related]
11. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
12. The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression.
Shu HK; Kim MM; Chen P; Furman F; Julin CM; Israel MA
Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14453-8. PubMed ID: 9826721
[TBL] [Abstract][Full Text] [Related]
13. One mechanism for cell type-specific regulation of the bax promoter by the tumor suppressor p53 is dictated by the p53 response element.
Thornborrow EC; Manfredi JJ
J Biol Chem; 1999 Nov; 274(47):33747-56. PubMed ID: 10559267
[TBL] [Abstract][Full Text] [Related]
14. Effects of wild-type and mutated p53 and Id proteins on the induction of apoptosis by adenovirus E1A, c-Myc, Bax, and Nip3 in p53 null mouse cerebellum cells.
Tsunoda H; Terasawa T; Yageta M; Nakajima T; Tomooka Y; Tsuchida N; Oda K
Biochem Biophys Res Commun; 1999 Feb; 255(3):722-30. PubMed ID: 10049778
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines.
Bentires-Alj M; Dejardin E; Viatour P; Van Lint C; Froesch B; Reed JC; Merville MP; Bours V
Oncogene; 2001 May; 20(22):2805-13. PubMed ID: 11420692
[TBL] [Abstract][Full Text] [Related]
16. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo.
Burns TF; Bernhard EJ; El-Deiry WS
Oncogene; 2001 Aug; 20(34):4601-12. PubMed ID: 11498783
[TBL] [Abstract][Full Text] [Related]
17. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
Inga A; Resnick MA
Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
[TBL] [Abstract][Full Text] [Related]
18. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
Hastak K; Gupta S; Ahmad N; Agarwal MK; Agarwal ML; Mukhtar H
Oncogene; 2003 Jul; 22(31):4851-9. PubMed ID: 12894226
[TBL] [Abstract][Full Text] [Related]
19. The Brn-3a transcription factor inhibits the pro-apoptotic effect of p53 and enhances cell cycle arrest by differentially regulating the activity of the p53 target genes encoding Bax and p21(CIP1/Waf1).
Budram-Mahadeo V; Morris PJ; Latchman DS
Oncogene; 2002 Sep; 21(39):6123-31. PubMed ID: 12203124
[TBL] [Abstract][Full Text] [Related]
20. Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells.
Gottlieb E; Lindner S; Oren M
Cell Growth Differ; 1996 Mar; 7(3):301-10. PubMed ID: 8838860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
